EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor‐Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia

Alana Costa de Oliveira, Diego de Carvalho Carneiro iD, Luiza Carolina França Opretzka iD, Breno Cardim Barreto iD, Dahara Keyse Carvalho Silva, Girlaine Café Santos, Cássio Santana Meira iD, Milena Botelho Pereira Soares iD

Microbiology and Immunology · 02.11.2026

DOI: 10.1111/1348-0421.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology and Immunology, online erschienen am 02.11.2026. Verfasst von Alana Costa de Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life‐threatening condition characterized by dysregulated systemic inflammation and high mortality rates. Mesenchymal stem/stromal cells (MSCs) have emerged as promising immunomodulatory agents; however, genetic engineering strategies can enhance their therapeutic efficacy. This study evaluated the immunomodulatory and protective effects of MSCs genetically engineered to express leukemia inhibitory factor (MSC‐LIF) in vitro and in a mouse model of lipopolysaccharide (LPS)‐induced endotoxemia. In vitro, peritoneal macrophages stimulated with LPS + IFN‐γ were co‐cultured with MSC‐LIF or wild‐type MSCs (MSC‐WT). MSC‐LIF significantly reduced the production of TNF‐α, IL‐12, and nitric oxide compared with stimulated controls and demonstrated enhanced inhibition of IL‐12 and nitrite levels relative to MSC‐WT. Although IL‐6 levels increased in co‐cultures, MSC‐LIF promoted a regulatory cytokine profile characterized by modulation of pro‐inflammatory mediators. In vivo, C57BL/6 mice subjected to lethal endotoxemia with LPS were treated with MSC‐LIF, MSC‐WT, dexamethasone, or vehicle. MSC‐LIF significantly improved survival in a dose‐dependent manner, achieving 100% survival at the highest dose (1 × 10 6 cells), outperforming MSC‐WT. Serum cytokine analysis revealed that MSC‐LIF markedly reduced TNF‐α, IL‐6, IL‐1β, and IL‐12 levels while significantly increasing IL‐10 production, indicating enhanced systemic immunoregulation. Collectively, these findings demonstrate that LIF expression potentiates the immunomodulatory and protective effects of MSCs in experimental endotoxemia. MSC‐LIF therapy promotes a balanced inflammatory response and significantly improves survival, supporting its potential as a novel therapeutic strategy for severe systemic inflammatory conditions such as sepsis.

Schlagwörter

Stichwörter der Autor:innen

endotoxemiaimmunomodulationinflammationleukemia inhibitory factormesenchymal stromal cellssepsis

Autor:innen und Institutionen

  • Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil.
  • Instituto SENAI de Inovação em Sistemas Avançados de Saúde (ISI SAS), Universidade SENAI CIMATEC, Salvador, Bahia, Brazil.

ORCID-Profile: Diego de Carvalho Carneiro, Luiza Carolina França Opretzka, Breno Cardim Barreto, Cássio Santana Meira, Milena Botelho Pereira Soares

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Oswaldo Cruz

Zitieren

APA

Oliveira, A. C., Carneiro, D. C., Opretzka, L. C. F., Barreto, B. C., Silva, D. K. C., Santos, G. C., Meira, C. S., & Soares, M. B. P. (2026). In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor‐Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.70102

Vancouver

Oliveira AC, Carneiro DC, Opretzka LCF, Barreto BC, Silva DKC, Santos GC, et al. In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor‐Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia. Microbiology and Immunology. 2026. doi:10.1111/1348-0421.70102

BibTeX
@article{Oliveira2026,
  author = {Oliveira, Alana Costa de and Carneiro, Diego de Carvalho and Opretzka, Luiza Carolina França and Barreto, Breno Cardim and Silva, Dahara Keyse Carvalho and Santos, Girlaine Café and Meira, Cássio Santana and Soares, Milena Botelho Pereira},
  title = {In Vitro and In Vivo Immunomodulatory and Protective Effects of Leukemia Inhibitory Factor‐Engineered Mesenchymal Stromal Cells in Experimental Endotoxemia},
  journal = {Microbiology and Immunology},
  year = {2026},
  doi = {10.1111/1348-0421.70102}
}
Kostenlos starten →